Figures & data
Figure 1. Biomanufacturing diagrams for Process A (conventional fed-batch at 1000-L scale, n = 5), Process B (intensified fed-batch by enriched N-1 at 1000-L scale, n = 8), and Process C (intensified fed-batch by perfusion N-1 at 2000-L scale, n = 3).
![Figure 1. Biomanufacturing diagrams for Process A (conventional fed-batch at 1000-L scale, n = 5), Process B (intensified fed-batch by enriched N-1 at 1000-L scale, n = 8), and Process C (intensified fed-batch by perfusion N-1 at 2000-L scale, n = 3).](/cms/asset/c0e0ccfa-80fe-412b-86d2-56a911def90c/kmab_a_1770669_f0001_oc.jpg)
Figure 2. N-1 seed culture profiles (a) VCD; (b) cell viability and fed-batch production culture performance profiles; (c) VCD; (d) cell viability; (e) normalized titer; (f) normalized cell-specific productivity in the mAb biomanufacturing using Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation.
![Figure 2. N-1 seed culture profiles (a) VCD; (b) cell viability and fed-batch production culture performance profiles; (c) VCD; (d) cell viability; (e) normalized titer; (f) normalized cell-specific productivity in the mAb biomanufacturing using Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation.](/cms/asset/15e5ca59-3ecc-4470-ab39-b87d54616a03/kmab_a_1770669_f0002_b.gif)
Figure 3. Scale-up related metabolites and parameters: (a) lactate; (b) NH4; (c) CO2; (d) osmolality; for fed-batch production Process A (n = 3), Process B (n = 8) and Process C (n = 3). There are only triplicate data available for lactate, CO2, and osmolality out of five Process A batches, while no NH4 data available for Process A. Values are reported as average ± standard deviation.
![Figure 3. Scale-up related metabolites and parameters: (a) lactate; (b) NH4; (c) CO2; (d) osmolality; for fed-batch production Process A (n = 3), Process B (n = 8) and Process C (n = 3). There are only triplicate data available for lactate, CO2, and osmolality out of five Process A batches, while no NH4 data available for Process A. Values are reported as average ± standard deviation.](/cms/asset/15fbf435-63bd-4334-a5b8-9a8aed6cc8c0/kmab_a_1770669_f0003_b.gif)
Figure 4. Product yields at different downstream steps in the mAb biomanufacturing using Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation. N/A, not applicable.
![Figure 4. Product yields at different downstream steps in the mAb biomanufacturing using Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation. N/A, not applicable.](/cms/asset/e4e28cbe-763c-4ad3-883f-2e94eb83bc2a/kmab_a_1770669_f0004_b.gif)
Figure 5. In-process quality attributes: (a) HMW; (b) HCP; (c) DNA; (d) rProA; at different downstream steps in the mAb biomanufacturing using Process A (n = 3), Process B (n = 3), and Process C (n = 3). *Below detection limit. Values are reported as average ± standard deviation.
![Figure 5. In-process quality attributes: (a) HMW; (b) HCP; (c) DNA; (d) rProA; at different downstream steps in the mAb biomanufacturing using Process A (n = 3), Process B (n = 3), and Process C (n = 3). *Below detection limit. Values are reported as average ± standard deviation.](/cms/asset/b1a031fc-d4ef-4867-b2e9-e4db6e6c7648/kmab_a_1770669_f0005_b.gif)
Figure 6. Quality attributes (charge variant species, N-linked glycans, SEC impurities and ELISA potency) for final DS batches manufactured with Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation.
![Figure 6. Quality attributes (charge variant species, N-linked glycans, SEC impurities and ELISA potency) for final DS batches manufactured with Process A (n = 5), Process B (n = 8), and Process C (n = 3). Values are reported as average ± standard deviation.](/cms/asset/9296dc8d-8bd0-4d51-858f-8ed165a245cb/kmab_a_1770669_f0006_b.gif)
Table 1. Assumptions for COG Analysis.